ZNF2

Across TCGA pan-cancer cohorts, ZNF2 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ZNF2 data layer compared with 29 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZNF2 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUSC, and THCA are the cancer types where ZNF2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.625	.007	22	view →
LUSC	DFS	Median	All	0.441	0.753	.009	12	view →
THCA	DFS	Median	All	0.161	0.829	.007	9	view →
MESO	DFS	Median	III,IV	0.078	0.376	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ZNF2–UCEC (DFS)

Open the UCEC breakdown →